Filing metadata

Accession number
0001104659-22-085790
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Aug 03, 2022
Reporting period
Aug 01, 2020
Description
Insider transaction

Explore SEC Filings Hub